Showing results (1241-1250 of 1,306) with videos related to

Sort By:
Pageof 131
Molecular Genetics and Metabolism|August 13, 2011
Down syndrome: national conference on patient registries, research databases, and biobanksMary Lou Oster-Granite, Melissa A Parisi, Leonard Abbeduto, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|May 7, 2014
Clinical correlates and genetic linkage of social and communication difficulties in families with obsessive-compulsive disorder: Results from the OCD Collaborative Genetics StudyJack Samuels, Yin Yao Shugart, Ying Wang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 9, 2022
Antiretroviral Initiation at ≥800 CD4+ Cells/mm3 Associated With Lower Human Immunodeficiency Virus Reservoir SizeThomas A Rasmussen, Sunil K Ahuja, Locadiah Kuwanda, et al.
Clinical Epidemiology|June 12, 2026
The Danish Database for Hepatitis B and C (DANHEP): A Nationwide, Prospective, Ongoing Cohort StudySigne Bollerup, Christina Sølund, Sofie Hallager, et al.
Vaccine|June 23, 2011
Prime-boost vaccination with heterologous live vectors encoding SIV gag and multimeric HIV-1 gp160 protein: efficacy against repeated mucosal R5 clade C SHIV challengesSamir K Lakhashe, Vijayakumar Velu, Gaia Sciaranghella, et al.
Comprehensive Psychiatry|December 5, 2016
Parental bonding and hoarding in obsessive-compulsive disorderDavid Chen, O Joseph Bienvenu, Janice Krasnow, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 23, 2017
Short-Course Toll-Like Receptor 9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals With Human Immunodeficiency Virus InfectionLine Vibholm, Mariane H Schleimann, Jesper F Højen, et al.
Psychiatry Research|June 3, 2008
Further development of YBOCS dimensions in the OCD Collaborative Genetics study: symptoms vs. categoriesAnthony Pinto, Benjamin D Greenberg, Marco A Grados, et al.
JAMA Network Open|February 4, 2022
Prevalence of Select New Symptoms and Conditions Among Persons Aged Younger Than 20 Years and 20 Years or Older at 31 to 150 Days After Testing Positive or Negative for SARS-CoV-2Alfonso C Hernandez-Romieu, Thomas W Carton, Sharon Saydah, et al.
Science Translational Medicine|January 26, 2022
Pembrolizumab induces HIV latency reversal in people living with HIV and cancer on antiretroviral therapyThomas S Uldrick, Scott V Adams, Remi Fromentin, et al.
Pageof 131